Your browser doesn't support javascript.
loading
Optimizing Clozapine Benefit While Minimizing Adverse Effects with Concomitant Fluvoxamine Treatment in an Adolescent with Schizoaffective Disorder.
Rice, Timothy; Friedman, Stephanie; Tatum, Jasmine; Weiss-Goldman, Naomi; Kufert, Yael; Coffey, Barbara J.
Affiliation
  • Rice T; 1 Icahn School of Medicine at Mount Sinai, New York, New York.
  • Friedman S; 1 Icahn School of Medicine at Mount Sinai, New York, New York.
  • Tatum J; 1 Icahn School of Medicine at Mount Sinai, New York, New York.
  • Weiss-Goldman N; 1 Icahn School of Medicine at Mount Sinai, New York, New York.
  • Kufert Y; 1 Icahn School of Medicine at Mount Sinai, New York, New York.
  • Coffey BJ; 2 Department of Psychiatry and Behavioral Science, Miller School of Medicine, University of Miami, Miami, Florida.
J Child Adolesc Psychopharmacol ; 29(1): 66-71, 2019 02.
Article in En | MEDLINE | ID: mdl-30681385

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Serotonin Antagonists / Anti-Anxiety Agents / Fluvoxamine / Clozapine Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2019 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Serotonin Antagonists / Anti-Anxiety Agents / Fluvoxamine / Clozapine Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2019 Document type: Article Country of publication: United States